![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Tokyo Metropolitan Komagome Hospital, Kyoto University Hospital, and Aichi Cancer Center used a lens applicator microwave equipment, the HTS-100, to treat 90 patients with a total of 96 tumours. The results were analysed, and the following conclusions reached. Three clinical cases have been presented to illustrate the features of the HTS-100. (1) The results of 383 heating sessions using the HTS-100 were analysed. Even tumours larger and deeper than 5 cm could be heated above 42°C. The heating area is much wider than that of the other 2450, 915, 430 MHz microwave heating equipments. (2) Hyperthermia treatment using the HTS-100 was combined with radiotherapy. The percentage effectiveness in terms of CRpˆa was 66.3 % for the 89 cases which could be evaluated. Even for tumours larger than 5 cm, and deeper than 4 cm, local control was achieved in 60.7%. Thus, the indications for microwave heating have been significantly expanded. (3) Combination of microwave heating and RF heating is a new protocol which also expands the indications for hyperthermia therapy. (4) The percentage of patients experiencing the side-effects of pain, a sensation of heat, and burns was 15.6 %, 6.3 %, and 3.6 %, respectively. Most of these side-effects were mild and temporary. The percentage of patients experiencing pain was higher than in conventional microwave heating, probably because the area of heating was wider. (5) In the future, the HTS-100 can be expected to play an important role in clinical cancer hyperthermia.